These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9860069)

  • 1. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
    Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
    Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.
    Schapel GJ; Beran RG; Vajda FJ; Berkovic SF; Mashford ML; Dunagan FM; Yuen WC; Davies G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):448-53. PubMed ID: 8505632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
    Sander JW; Patsalos PN; Oxley JR; Hamilton MJ; Yuen WC
    Epilepsy Res; 1990 Aug; 6(3):221-6. PubMed ID: 2272345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lamotrigine in refractory partial and general epilepsies].
    Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
    Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
    Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
    Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy.
    Eriksson AS; Knutsson E; Nergårdh A
    Epilepsia; 2001 Feb; 42(2):230-6. PubMed ID: 11240595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
    Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
    Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
    Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
    Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin and lamotrigine in refractory epilepsy.
    Stolarek I; Blacklaw J; Forrest G; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):921-4. PubMed ID: 8057114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.